Fenton Mary Kay sold CGEM
February 20, 2026 · Form 4 insider transaction
Fenton Mary Kay sold 4,398 shares of Cullinan Therapeutics, Inc. at $13.62 per share, a transaction worth $59.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,398
Price
$13.62
Total value
$59.9K
InsiderFenton Mary Kay
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 20, 2026
Filing dateFebruary 23, 2026
Shares owned after126,380
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.